J. Riggert
- Hematology top 2%
- Blood groups and transfusion 13
- Platelet Disorders and Treatments 12
- Hematopoietic Stem Cell Transplantation 11
- Biochemistry top 2%
- Blood transfusion and management 12
- Microbiology top 2%
- Immunology top 5%
- Immunotherapy and Immune Responses 8
- T-cell and B-cell Immunology 4
-
- Blood donation and transfusion practices 6
-
- Erythrocyte Function and Pathophysiology 5
- Co-authors
- Afsaneh SoruriJörg ZwirnerMichael KöhlerAndreas HumpeUlf ForssmannG. SimsonTobias J. LeglerKatrin Schäfer
- Cited by
- HematologyBiochemistryMicrobiology
In The Last Decade
J. Riggert
72 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 110
- Hematology 502
- Biochemistry 231
- Microbiology 187
- Immunology 479
- Management of Technology and Innovation 107
Countries citing papers authored by J. Riggert
This map shows the geographic impact of J. Riggert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Riggert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Riggert more than expected).
Fields of papers citing papers by J. Riggert
This network shows the impact of papers produced by J. Riggert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Riggert. The network helps show where J. Riggert may publish in the future.
Co-authorship network
The 25 scholars most cited alongside J. Riggert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 4 | |
| 2 | 2023 | 2 | |
| 3 | 2019 | 51 | |
| 4 | 2007 | 125 | |
| 5 | 2007 | 122 | |
| 6 | 2007 | 3 | |
| 7 | 2004 | 4 | |
| 8 | 2004 | 13 | |
| 9 | 2003 | 51 | |
| 10 | 2003 | 57 | |
| 11 | 2001 | 3 | |
| 12 | 2001 | 22 | |
| 13 | 2000 | 24 | |
| 14 | 1999 | 31 | |
| 15 | 1997 | 96 | |
| 16 | 1997 | 37 | |
| 17 | 1997 | 31 | |
| 18 | 1996 | 33 | |
| 19 | 1995 | 7 | |
| 20 | 1995 | 23 |
About J. Riggert
J. Riggert is a scholar working on Hematology, Biochemistry, Management of Technology and Innovation, Internal Medicine and Immunology, having authored 75 papers that have together received 1.8k indexed citations. Recurring topics across this work include Blood groups and transfusion (13 papers), Blood transfusion and management (12 papers), Platelet Disorders and Treatments (12 papers), Hematopoietic Stem Cell Transplantation (11 papers), Immunotherapy and Immune Responses (8 papers), Blood donation and transfusion practices (6 papers), Erythrocyte Function and Pathophysiology (5 papers) and T-cell and B-cell Immunology (4 papers). The work is most often cited by research in Hematology (502 citations), Biochemistry (231 citations), Microbiology (187 citations), Immunology (479 citations) and Management of Technology and Innovation (107 citations). J. Riggert has collaborated with scholars based in Germany, Spain and Austria. Frequent co-authors include Afsaneh Soruri, Jörg Zwirner, Michael Köhler, Andreas Humpe, Ulf Forssmann, G. Simson, Tobias J. Legler, Katrin Schäfer, Gerd Hasenfuß and Stavros Konstantinides. Their work appears in journals such as Transfusion, Vox Sanguinis, Annals of Hematology, The Journal of Immunology and Alzheimer s Research & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.